BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33094285)

  • 1. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients.
    Scialò C; Tran TH; Salzano G; Novi G; Caponnetto C; Chiò A; Calvo A; Canosa A; Moda F; Caroppo P; Silani V; Ticozzi N; Ratti A; Borroni B; Benussi L; Ghidoni R; Furlanis G; Manganotti P; Senigagliesi B; Parisse P; Brasselet R; Buratti E; Legname G
    Brain Commun; 2020; 2(2):fcaa142. PubMed ID: 33094285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF.
    Audrain M; Egesipe AL; Tentillier N; Font L; Ratnam M; Mottier L; Clavel M; Le Roux-Bourdieu M; Fenyi A; Ollier R; Chevalier E; Guilhot F; Fuchs A; Piorkowska K; Carlyle B; Arnold SE; Berry JD; Luthi-Carter R; Adolfsson O; Pfeifer A; Kosco-Vilbois M; Seredenina T; Afroz T
    Brain Commun; 2023; 5(6):fcad306. PubMed ID: 38025276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
    Bosque PJ; Boyer PJ; Mishra P
    PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 cytoplasmic inclusion formation is disrupted in
    Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin LS; Li L; Glass JD
    Brain Commun; 2019; 1(1):fcz014. PubMed ID: 31633109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
    Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of TDP-43 in human cells and tissues by multiple reaction monitoring mass spectrometry.
    Pobran TD; Forgrave LM; Zheng YZ; Lim JGK; Mackenzie IRA; DeMarco ML
    Clin Mass Spectrom; 2019 Nov; 14 Pt B():66-73. PubMed ID: 34917762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
    Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
    Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.
    Charif SE; Vassallu MF; Salvañal L; Igaz LM
    Neural Regen Res; 2022 Jul; 17(7):1423-1430. PubMed ID: 34916412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
    Smethurst P; Sidle KC; Hardy J
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new subtype of frontotemporal lobar degeneration with FUS pathology.
    Neumann M; Rademakers R; Roeber S; Baker M; Kretzschmar HA; Mackenzie IR
    Brain; 2009 Nov; 132(Pt 11):2922-31. PubMed ID: 19674978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43.
    Uchida A; Sasaguri H; Kimura N; Tajiri M; Ohkubo T; Ono F; Sakaue F; Kanai K; Hirai T; Sano T; Shibuya K; Kobayashi M; Yamamoto M; Yokota S; Kubodera T; Tomori M; Sakaki K; Enomoto M; Hirai Y; Kumagai J; Yasutomi Y; Mochizuki H; Kuwabara S; Uchihara T; Mizusawa H; Yokota T
    Brain; 2012 Mar; 135(Pt 3):833-46. PubMed ID: 22252998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Steinacker P; Hendrich C; Sperfeld AD; Jesse S; von Arnim CA; Lehnert S; Pabst A; Uttner I; Tumani H; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph A; Neumann M; Otto M
    Arch Neurol; 2008 Nov; 65(11):1481-7. PubMed ID: 19001167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.
    Geser F; Prvulovic D; O'Dwyer L; Hardiman O; Bede P; Bokde AL; Trojanowski JQ; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):649-62. PubMed ID: 21911035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion.
    Junttila A; Kuvaja M; Hartikainen P; Siloaho M; Helisalmi S; Moilanen V; Kiviharju A; Jansson L; Tienari PJ; Remes AM; Herukka SK
    Dement Geriatr Cogn Dis Extra; 2016; 6(1):142-9. PubMed ID: 27195002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
    Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
    Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
    Neumann M
    Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.